Our findings highlight the need for investigations of the effects of APOE4 on inter-cell-type communications and interactions in the brain to identify new avenues for precision medicine treatment of at-risk APOE4 carriers and AD patients. The gene discussed is APOE; the disease is Alzheimer disease.